MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201

被引:74
作者
Lopez-Vazquez, A
Rodrigo, L
Fuentes, D
Riestra, S
Bousoño, C
Garcia-Fernandez, S
Martinez-Borra, J
Gonzalez, S
Lopez-Larrea, C
机构
[1] Hosp Cent Asturias, Serv Inmunol, Dept Immunol, Oviedo 33006, Spain
[2] Hosp Cent Asturias, Dept Gastroenterol, Oviedo 33006, Spain
[3] Hosp Cent Asturias, Dept Paediat, Oviedo 33006, Spain
[4] Hosp Valle Nalon, Gastroenterol Sect, Sama De Langreo, Asturias, Spain
[5] Univ Oviedo, Funct Biol Dept, Oviedo, Spain
关键词
D O I
10.1136/gut.50.3.336
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Coeliac disease (CD) is an enteropathic disorder characterised by a strong association with major histocompatibility complex (MHC) heterodimer HLA-DQ2. It has been suggested that other HLA class I genes in combination with DQ may also contribute to CD susceptibility. The aim of this study was to investigate whether other candidate genes modify the risk of developing different clinical forms of CD. Patients and methods: We studied 133 Spanish coeliac patients, divided according to their clinical presentation into typical and atypical groups, and 116 healthy controls. All were typed by polymerase chain reaction-sequence specific primers (PCR-SSP) at HLA-B, DRB1, DQA1, and DQB1 loci and for exon 5 of the MHC class I chain related gene A (MICA). Results: No differences were found in the frequency of the DQA1*0501/DQB1*0201 heterodimer in either group. The risk of typical CD was significantly associated with the DR7/DQ2 haplotype (p(c)=0.02, odds ratio (OR)=3.4, ethiological fraction (EF)=0.4). Extended haplotype (EH) 8.1 (B8/DR3/DQ2) was found to be overrepresented in the atypical form compared with the typical form (p(c)=0.001, OR=4.19, EF=0.56). The trinucleotide repeat polymorphism MICA-A5.1 was found to be increased in the atypical group of patients compared with the typical group (p(c)=0.00006, OR=8.63, EF=0.81). This association was independent of linkage disequilibrium with EH8.1 as this was also Central found to be increased in EH8.1 negative atypical patients compared with the typical group (p(c)=0.004,, OR=6.66, EF=0.56). Conclusions: Our results showed that the risk of developing typical forms of CD was associated with DR7/DQ2 haplotype and the presence of B8/DR3/DQ2 was significantly increased in atypical patients. In these, the MICA-A5.1 allele confers an additive effect to the DR3/DQ2 haplotype that may. modulate the development of CD.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 33 条
[1]   A 2ND LINEAGE OF MAMMALIAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENES [J].
BAHRAM, S ;
BRESNAHAN, M ;
GERAGHTY, DE ;
SPIES, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6259-6263
[2]   One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies [J].
Bao, F ;
Yu, LP ;
Babu, S ;
Wang, TB ;
Hoffenberg, EJ ;
Rewers, M ;
Eisenbarth, GS .
JOURNAL OF AUTOIMMUNITY, 1999, 13 (01) :143-148
[3]   The clinical pattern of subclinical silent celiac disease: An analysis on 1026 consecutive cases [J].
Bottaro, G ;
Cataldo, F ;
Rotolo, N ;
Spina, M ;
Corazza, GR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03) :691-696
[4]   COMPREHENSIVE, SEROLOGICALLY EQUIVALENT DNA TYPING FOR HLA-B BY PCR USING SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) [J].
BUNCE, M ;
FANNING, GC ;
WELSH, KI .
TISSUE ANTIGENS, 1995, 45 (02) :81-90
[5]   CELIAC-DISEASE IN THE YEAR 2000 - EXPLORING THE ICEBERG [J].
CATASSI, C ;
RATSCH, IM ;
FABIANI, E ;
ROSSINI, M ;
BORDICCHIA, F ;
CANDELA, F ;
COPPA, GV ;
GIORGI, PL .
LANCET, 1994, 343 (8891) :200-203
[6]   SUBCLINICAL CELIAC SPRUE - INCREASING OCCURRENCE AND CLUES TO ITS DIAGNOSIS [J].
CORAZZA, GR ;
FRISONI, M ;
TREGGIARI, EA ;
VALENTINI, RA ;
FILIPPONI, C ;
VOLTA, U ;
GASBARRINI, G .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1993, 16 (01) :16-21
[7]   Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease [J].
Dawkins, R ;
Leelayuwat, C ;
Gaudieri, S ;
Tay, G ;
Hui, J ;
Cattley, S ;
Martinez, P ;
Kulski, J .
IMMUNOLOGICAL REVIEWS, 1999, 167 :275-304
[8]   Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients [J].
Farré, C ;
Humbert, P ;
Vilar, P ;
Varea, V ;
Aldeguer, X ;
Carnicer, J ;
Carballo, M ;
Gassull, MA .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (11) :2344-2349
[9]   CLINICAL AND PATHOLOGICAL SPECTRUM OF CELIAC-DISEASE ACTIVE, SILENT, LATENT, POTENTIAL [J].
FERGUSON, A ;
ARRANZ, E ;
OMAHONY, S .
GUT, 1993, 34 (02) :150-151
[10]   HLA-LINKED GENES ACTING AS ADDITIVE SUSCEPTIBILITY FACTORS IN CELIAC-DISEASE [J].
FERNANDEZARQUERO, M ;
FIGUEREDO, MA ;
MALUENDA, C ;
DELACONCHA, EG .
HUMAN IMMUNOLOGY, 1995, 42 (04) :295-300